EXPEWENCES A L L O V E R T H E W O R L D
ha\.e proved the value of corticosteroid* in the treatment of pulmonary diceases, including tuberculosis." In 1958, having reported extensivel: on our work with these drugs, we recommended using corticosteroids for the shortest period necessary to obtain the desired effects. These are potent metabolic agents, and this recommendation still is a good one. However, a number of patients have clinical remisions when the corticoids are reduced too much or are discontinued. This group included patients with pulmonar! tuherculosis. chronic, severe, a l l e r~c bronchitis. pulmon a n fibrosis (specific and non-specific) .
lupus enthematosus, and pulmonan emph!sema. In view of these relapses, it waq necesQry to resume corticoid therapy, in an attempt to control the patient's q m p toms.
The opportunity of following 47 patients on 4 to 12 mg. triamcinolone for five to eight years allowed us to evaluate long term clinical effects, both beneficial and undesirable side reactions.'
This report is of a group of 47 patients, including 24 pulmonan tuberculosis, 11 chronic allergic bronchitis, three men with pulmonan fibrosis (two Hamman-Rich syndrome and one Lceffler's syndrome), one lupus erythematosus, and eight patients with chronic pulmonary emphysema.
There were 34 men and 13 women, varying in age from 37 years to 73 years: 34 Caucasians, 11 Negroes, and two Orientals.
.U1 of these patients had been hospitalized during their acute illness, at which time, in addition to chemotherapy, they received corticosteroids (in thic series triamcinolone [Kenacort] ). Initially, dosage varied from 32 to 40 mg., gradually reduced to maintenance dose of 2 to 8 mg.
daily. When this maintenance dose was reduced or the triamcinolone was discontinued, a clinical relapse was noted within two to eight days in thge 47 patient5. One hundred forty-three other patients of the original 190 patients in this study group were able to discontinue their corticosteroid therapy completely without adverse reactions.
All of the 47 patients had had beneficial clinical effects from the corticosteroids--since any who had undesirable side effects or no clinical improvement had been eliminated from this study. These patients enred as their own double controls, since they had been followed before receiving corticoids, when they received larger doses of these drugs, and in this study on long term maintenance therapy. The long term maintenance dose of 2 to 8 mg. was administered once daily after breakfast to 41 of the 47 patients.'
Pulmonary T u berculosir-There were 24 patients with chronic disease, who were not getting any better, nor any worn-who had intermittent positi\.e sputa, and x-ray evidence of active tuberculosis--on triamcinolone and antituberculosis chemotherapy. There had been a definite weight gain, improved mental outlook, and x-ray evidence of improvement. These beneficial effects continued in all but two patients, who died. One had a massive pulmonary hemorrhage after five years and three months, and the other had an acute anterior coronary infarction as he began his sixth year of corticmteroid therapy. Chronic Severe Allergic Bronchitis-The 11 patients studied all had multiple perennial allergies. They had had desensitization regimens and antihistamines, prior to W i g treated with corticmteroids. This group had beneficial effects with control of acute symptoms, but ac the dasage of triamcinolone was reduced, attacks of wheeztriamcinolone (plus "prophylactic" isoniazid). . h the corticostemid was reduced, within one week cough returned, dyspnea recurred and in one patient who was without triamcinolone for t h m weeks, there was evidence of pulmonary infiltration. All four patients have been maintained on 2 to 6 mg. triamcinolone daily for five years and six months to seven years ( Fig. 1 ) .
Pulmonary Emphysema-Although the value of corticostemids alone in the treating and dppnea recumd. .-\ number of patients, not included in this study, were controlled with corticosteroids during their attacks, and did not require long term therapy. On maintenance dosag, 2 to 8 mg. daily, they were generally controlled. When the patient was exposed to a high concentration of the offending allergen, there was an exacerbation. relieved with increased dasage for two to three da!s. Then the drug was decreased to maintenance dose. One of the patients moved to Arizona after five years of triamcinolone therapy.
Pulmonary Fibrosis, including Lupus Erylhematosus-Among the three patients with pulmonary fibrosis and one with lupus erythcmatosus with pulmonary involvement, there had been marked x-ray clearing and symptomatic improvement with ment of pulmonary e m p h p m a is equivocal, when combined with other measures, it is often excellent a d j u n c t therapy. Among a group of 47 patients who had bronchwopic drainage, autogenous vaccines, intermittent positive pressure breathing, antibiotics, breathing exercises, with triamcinolone, there was subjective and objective impro\rement. There were eight patients in this p u p who showed evidence of relapse when triamcinolone was discontinued although other therapy was maintained. T h e patients were supported on 2 to 8 mg. triamcinolone daily for five to eight years, with good symptomatic control.
The following chart (Table 1 ) compares side effects on short term (60 day) and long term (five to eight yeas) treatment with corticosteroids. Of greatest intere n is the large number of patients exhibiting moon faces (Cushingoid syndrome), the one fatal pulmonary hemorrhage and the one almost silent coronary infarction. In view of the reported high incidence of osteoporosis with chronic corticoid therapy, all patients were maintained on a high protein diet with adequate fluid intake. At the onset of this study, 20 patients served as controls while 27 others received anabolic steroids'" (combination of androgen and estrogen). Twelve of the 20 controls showed clinical and/or x-ray evidence of osteoporosis while only one of the 27 receiving anabolic steroids had evidence of osteoporosis. One patient, not included in this study, who was taking corticosteroids without supervision, developed marked osteoporosis (Fig. 2 ) .
Long term, maintenance or supportive ( 2 to 12 mg. daily) treatment with corticosteroids is often necessary to maintain symptomatic improvement. In this study, we found the same clinical action whether the corticoid was given once daily, or in divided doses. This tends to confirm the recent report of Demos, et al.' on once daily therapy.
The beneficial effects can be complicated by undesirable side reactions. For s u p portive and prophylactic care, all patients were on high protein die& (re: o s t e o p rosis) ; in between feeding, milk, etc. (re: ulcer) ; adequate water intake (avoiding a concentrated urine with hypercalciuria) ; isoniand 100 mg. three times a d a y (against reactivating tuberculosis) with regular complete examinations, including laborator) evaluation. The concurrent administration of anabolic steroids (androgen and estrogen) has been shown to control osteoporosis. Unfortunately, the moon faces often appear early in the coursc of treatment and penbt in a large group of patients.
Finally, the corticosteroids are potent, effective d r u g for acute and chronic pulmonary diseases. They should be used with discretion, when indicated, under c l m clinical supervision. El tratamiento a largo plam con dosir de mant e~m i e n t o de conicoesteroides ( 2 a 12 mg. diarios) rs frecuentemente necesrria para mantener la mejoria sintomatica. En nuestn experiencia hemos observado identico cferto cliico con doris unicas o fnccionadas, lo que tiende a confirmar los ohservaciones de Demos et 01.' con el metoda de dosis unica diaria.
Los efectos beneficioros pueden aparecer acornpaKados de efectos secundarios indesrables. Todos nuestm c a m en curso de tratamiento profilactico o de mantenimiento recibian una dieta hiperpmteinica ( p a n contnrrestar la tendencia a la osteoporosis) tomar de aliment0 leche etc. entre comidas (ulcera) y adecuada rantidad de tiquidos ( p a n evitar la concentncion urinaria con hipercalciuriai a mir de hidnzida del acido isonicotiniro (INH) 100 mgm. tres wces al dia ( p a n prevenir las reactivaciones tuberculosasi. E m ademas sametidos a examener rlinicos a intenalos regulares, incluyendo pruebas de laboratorio. La administncion cancurrente d r esteroides anabolicos (androgen0 y estrogeno) es de reconocido efecto para la prevention o control d r La osteoporosis. Es de lamentar que la "can de luna" aparece con frecuencia en el CUM del tratamiento y peniste en muchos rasos.
Los conicoesteroides son agentes potentes y efectivos en el tratamiento de la tuberculosis aguda o cronica. Su emplro sin embargo requiere discretion, indicaciones precisan y supervision clinica mrecha. 
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